GCIA
CELG

Gabelli & Co Investment Advisers’s Celgene Corp CELG Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-544,390
Closed -$54.1M – 249
2019
Q3 		$54.1M Buy
544,390
+41,470
+8% +$3.94M 6.08% 2
2019
Q2 		$46.5M Buy
502,920
+174,594
+53% +$16.6M 4.98% 3
2019
Q1 		$31M Buy
+328,326
New +$28.7M 3.99% 6

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Gabelli & Co Investment Advisers's CELG Position: Q4 2019 in Review

Gabelli & Co Investment Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 544,390 shares — an estimated $54.1M sold.

Gabelli & Co Investment Advisers first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $54.1M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Gabelli & Co Investment Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 544,390 Celgene Corp shares in Q4 2019, an estimated $54.1M.
  • Gabelli & Co Investment Advisers first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Gabelli & Co Investment Advisers's Celgene Corp position peaked at $54.1M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.